Centricity Vision
Private Company
Total funding raised: $15M
Overview
Centricity Vision is a private, commercial-stage medical device company focused on the cataract surgery market. Its core innovation is the ZEPTOLink IOL Positioning System, which automates a critical step in cataract surgery—the capsulotomy—to improve lens positioning and surgical outcomes. The company has achieved FDA clearance and commercial launch for ZEPTOLink, positioning it in the large and growing global cataract surgery market. Recent leadership changes and platform enhancements indicate an active commercial and product development strategy.
Technology Platform
Precision pulse capsulotomy technology (ZEPTO®) integrated into a phaco-compatible surgical platform (ZEPTOLink) for automated, circular capsulotomy creation in cataract surgery.
Funding History
1Opportunities
Risk Factors
Competitive Landscape
Centricity Vision competes in the advanced cataract surgery device segment against giants like Alcon (with its Centurion Vision System and Catalys femtosecond laser) and Johnson & Johnson Vision (with its VERION system). Its primary differentiation is offering a dedicated, automated capsulotomy solution that integrates into existing workflows, as opposed to more comprehensive (and expensive) femtosecond laser platforms or manual techniques.